CORE-URO-01 study: comparison of safety and efficacy of pazopanib in first-line metastatic renal cell carcinoma (mRCC) with or without renal failure / Masini, C; Vitale, Mg; Maruzzo, M; Procopio, G; De Giorgi, U; Buti, S; Rossetti, S; Iacovelli, R; Guida, A; Atzori, F; Mucciarini, C; Scagliarini, S; Vignani, F; Prati, G; Cosmai, L; Berselli, A; Pinto, C. - In: ANNALS OF ONCOLOGY. - ISSN 0923-7534. - 28:Supplement 5(2017), pp. 321-321.

CORE-URO-01 study: comparison of safety and efficacy of pazopanib in first-line metastatic renal cell carcinoma (mRCC) with or without renal failure

Buti S;
2017

CORE-URO-01 study: comparison of safety and efficacy of pazopanib in first-line metastatic renal cell carcinoma (mRCC) with or without renal failure / Masini, C; Vitale, Mg; Maruzzo, M; Procopio, G; De Giorgi, U; Buti, S; Rossetti, S; Iacovelli, R; Guida, A; Atzori, F; Mucciarini, C; Scagliarini, S; Vignani, F; Prati, G; Cosmai, L; Berselli, A; Pinto, C. - In: ANNALS OF ONCOLOGY. - ISSN 0923-7534. - 28:Supplement 5(2017), pp. 321-321.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2906911
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact